Simon Agwale, Ph.D is the founder and CEO of INNOVATIVE BIOTECH LTD, Keffi, Nigeria Innovative Biotech USA Inc., Minerals for Life LTD, Nigeria and Innovative Vaccines LTD, Nigeria. He has been at the forefront of shaping the future direction of vaccine development worldwide. Dr. Agwale is a highly respected virologist/vaccinologist especially with regard to his work on HIV vaccine development. He has a vision for the development and investigation of HIV vaccine constructs from prevalent Nigerian strains which are relevant to Nigerians.Furthermore, Dr. Agwale is currently developing a manufacturing process for conjugate typhoid vaccine which has a potential for eradication of typhoid fever worldwide. With over 20 years experience combining top-level scientific research with the operations of a Biotech company, he has been involved in academic research at various institutions in Nigeria, Germany, the UK, and the United States.

Dr. Agwale was West Africa's representative on HIV/AIDS for Developing countries Coordinating Committee (DCCC) at European and Developing Countries Clinical Trials Programme (EDCTP; www.edctp.org), where he was also the chair of the African Scientists committee (DCCC). Furthermore, he is a member and a steering committee member of the Nigeria Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA).

Dr. Agwale has represented Nigeria and Africa at various local and international scientific fora including assignment as temporary adviser to WHO/UNAIDS. Furthermore, he is an active member of the West African Consortium (WANETAM) to prepare West Africa for the conduct of clinical trials of drugs/vaccines against TB, AIDS and Malaria.